BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38345134)

  • 41. MultiRBE: Treatment planning for protons with selective radiobiological effectiveness.
    Sánchez-Parcerisa D; López-Aguirre M; Dolcet Llerena A; Udías JM
    Med Phys; 2019 Sep; 46(9):4276-4284. PubMed ID: 31310683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploration and application of phenomenological RBE models for proton therapy.
    Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
    Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of potentially variable RBE in liver proton therapy.
    Chen Y; Grassberger C; Li J; Hong TS; Paganetti H
    Phys Med Biol; 2018 Sep; 63(19):195001. PubMed ID: 30183674
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Multiple Beams on Plan Quality, Linear Energy Transfer Distribution, and Plan Robustness of Intensity Modulated Proton Therapy for Lung Cancer.
    Shang H; Pu Y; Chen Z; Wang X; Yuan C; Jin X; Liu C
    ACS Sens; 2021 Feb; 6(2):408-417. PubMed ID: 33125211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.
    Buchsbaum JC; McDonald MW; Johnstone PA; Hoene T; Mendonca M; Cheng CW; Das IJ; McMullen KP; Wolanski MR
    Radiat Oncol; 2014 Jan; 9():2. PubMed ID: 24383792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RBE-weighted dose and its impact on the risk of acute coronary event for breast cancer patients treated with intensity modulated proton therapy.
    Liu C; Bradley JA; Zheng D; Vega RBM; Beltran CJ; Mendenhall N; Liang X
    J Appl Clin Med Phys; 2022 Apr; 23(4):e13527. PubMed ID: 35060317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incorporation of relative biological effectiveness uncertainties into proton plan robustness evaluation.
    Ödén J; Eriksson K; Toma-Dasu I
    Acta Oncol; 2017 Jun; 56(6):769-778. PubMed ID: 28464736
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
    Giantsoudi D; Adams J; MacDonald SM; Paganetti H
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deep learning-based synthetic dose-weighted LET map generation for intensity modulated proton therapy.
    Gao Y; Chang CW; Pan S; Peng J; Ma C; Patel P; Roper J; Zhou J; Yang X
    Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38091613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Robust optimization to reduce the impact of biological effect variation from physical uncertainties in intensity-modulated proton therapy.
    Bai X; Lim G; Grosshans D; Mohan R; Cao W
    Phys Med Biol; 2019 Jan; 64(2):025004. PubMed ID: 30523932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
    Stützer K; Lin A; Kirk M; Lin L
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variance-based sensitivity analysis for uncertainties in proton therapy: A framework to assess the effect of simultaneous uncertainties in range, positioning, and RBE model predictions on RBE-weighted dose distributions.
    Hofmaier J; Dedes G; Carlson DJ; Parodi K; Belka C; Kamp F
    Med Phys; 2021 Feb; 48(2):805-818. PubMed ID: 33210739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.
    Resch AF; Landry G; Kamp F; Cabal G; Belka C; Wilkens JJ; Parodi K; Dedes G
    Phys Med; 2017 Apr; 36():91-102. PubMed ID: 28410691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
    Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
    Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
    [No Abstract]   [Full Text] [Related]  

  • 55. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
    Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
    Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simultaneous optimization of RBE-weighted dose and nanometric ionization distributions in treatment planning with carbon ions.
    Burigo LN; Ramos-Méndez J; Bangert M; Schulte RW; Faddegon B
    Phys Med Biol; 2019 Jan; 64(1):015015. PubMed ID: 30523890
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.
    Liu W; Frank SJ; Li X; Li Y; Park PC; Dong L; Ronald Zhu X; Mohan R
    Med Phys; 2013 May; 40(5):051711. PubMed ID: 23635259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
    Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
    Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment.
    Chaudhary P; Marshall TI; Perozziello FM; Manti L; Currell FJ; Hanton F; McMahon SJ; Kavanagh JN; Cirrone GA; Romano F; Prise KM; Schettino G
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):27-35. PubMed ID: 24986743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
    Weber DC; Trofimov AV; Delaney TF; Bortfeld T
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.